- Home
- FLX vs CRMD Comparison
FLX vs CRMD Comparison
Compare FLX & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLX
- CRMD
- Stock Information
- Founded
- FLX 2013
- CRMD 2006
- Country
- FLX China
- CRMD United States
- Employees
- FLX N/A
- CRMD N/A
- Industry
- FLX
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- FLX
- CRMD Health Care
- Exchange
- FLX NYSE
- CRMD Nasdaq
- Market Cap
- FLX N/A
- CRMD 973.3M
- IPO Year
- FLX 2024
- CRMD 2010
- Fundamental
- Price
- FLX $3.27
- CRMD $11.40
- Analyst Decision
- FLX
- CRMD Strong Buy
- Analyst Count
- FLX 0
- CRMD 7
- Target Price
- FLX N/A
- CRMD $17.33
- AVG Volume (30 Days)
- FLX 96.0K
- CRMD 2.5M
- Earning Date
- FLX 08-27-2025
- CRMD 08-13-2025
- Dividend Yield
- FLX N/A
- CRMD N/A
- EPS Growth
- FLX N/A
- CRMD N/A
- EPS
- FLX N/A
- CRMD 0.28
- Revenue
- FLX $595,490,250.00
- CRMD $82,553,827.00
- Revenue This Year
- FLX N/A
- CRMD $238.38
- Revenue Next Year
- FLX N/A
- CRMD $53.52
- P/E Ratio
- FLX N/A
- CRMD $41.86
- Revenue Growth
- FLX N/A
- CRMD N/A
- 52 Week Low
- FLX $2.01
- CRMD $3.61
- 52 Week High
- FLX $21.95
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- FLX N/A
- CRMD 39.52
- Support Level
- FLX N/A
- CRMD $12.14
- Resistance Level
- FLX N/A
- CRMD $17.43
- Average True Range (ATR)
- FLX 0.00
- CRMD 0.69
- MACD
- FLX 0.00
- CRMD -0.51
- Stochastic Oscillator
- FLX 0.00
- CRMD 4.60
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.